Professional
Added to YB: 2025-07-17
Pitch date: 2025-07-09
ICLR [neutral]
ICON Public Limited Company
+22.27%
current return
Author Info
No bio for this author
Company Info
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
Market Cap
$12.6B
Pitch Price
$150.79
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.01
P/E
22.02
EV/Sales
1.93
Sector
Life Sciences Tools and Services
Category
growth
LRT Capital Management Portfolio Holding: ICON Public Limited Company
ICLR (holding update): Premier global CRO with insurmountable competitive moat from scale, therapeutic expertise & tech solutions. Critical partner in complex drug development process with high switching costs creating stable recurring revenue. PRA acquisition enhanced capabilities. Management executing disciplined end-to-end strategy amid growing R&D outsourcing trend.
Read full article (2 min)